Success Stories: Targeted Antibiotic Delivery Research Leads to NIW Approval
Client’s Testimonial:
“Thank you for your support during the filing process of I-480, which was finally approved.”
On February 26th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Student in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: PhD Student
Country of Origin: Nepal
State of Residence at the Time of Filing: Ohio
Approval Notice Date: February 26th, 2025
Processing Time: 1 year, 3 months, 16 days
Case Summary:
Surgery site infections and implant rejection remain two of the most common and costly complications in modern healthcare. These challenges cause patient suffering, prolong hospital stays, and increase healthcare costs nationwide. Addressing these problems requires innovation in both antibiotic delivery and implant design, areas where North America Immigration Law Group (NAILG) successfully secured an EB-2 NIW approval for a biomedical engineering expert whose work is paving the way for safer and more effective medical technologies.
Our client has developed sustainable, on-demand, targeted antibiotic delivery systems designed to administer treatment precisely where it is most needed. This approach represents a breakthrough in postoperative care by reducing complications, limiting the overuse of antibiotics, and accelerating recovery. Alongside this work, she has advanced the synthesis of optimized novel metal alloys using spark plasma sintering (SPS), enabling the creation of implants that minimize rejection rates and enhance biocompatibility. Together, these contributions have the potential to significantly improve outcomes for patients who rely on orthopedic and other surgical implants.
Her record reflects both productivity and influence:
- 3 peer-reviewed journal articles (2 first-authored), 1 book chapter.
- 53 citations of her research.
- Funding support from the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
Experts in the field have recognized the importance of her work, noting:
“As such, the ability to replace major vital organ tissue with minimally invasive techniques offers substantially extended life expectancy, among other positive medical intervention outcomes, representing an area of significant need to advance the interests and priorities of the United States. In this way, [Client]’s continued research and technological advancement in the field of biomedical engineering are of great national and international importance.”
By strategically framing her innovations in targeted drug delivery and implant development, NAILG presented a compelling petition that clearly demonstrated both the national importance of her work and her ability to continue advancing it. This persuasive case led to USCIS approval of her NIW petition, ensuring that her research will continue to shape the future of biomedical engineering and improve patient care across the United States.

